ALK and non-small cell lung carcinoma: ALK IHC has been automated for comprehensive screening for ALK rearrangement in NSCLC with 100% sensitivity and 98% specificity (98%) [25] and could be employed as the screening strategy for ALK rearrangement in CRC.